Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report) was the recipient of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 455 shares. Based on an average daily trading volume, of 13,889 shares, the short-interest ratio is presently 0.0 days.
Fortress Biotech Stock Down 3.6%
FBIOP stock opened at $13.85 on Tuesday. Fortress Biotech has a one year low of $6.50 and a one year high of $21.43. The company has a fifty day moving average price of $16.67 and a two-hundred day moving average price of $16.37.
Fortress Biotech Company Profile
Fortress Biotech, Inc. is a U.S.-based biopharmaceutical company that acquires, develops and commercializes prescription medicines. Its work spans areas including oncology, rare diseases, dermatology and other specialty markets. The company operates through a network of subsidiary businesses and uses partnerships and licensing arrangements to advance drug candidates and bring therapies to market. Its portfolio includes both development-stage programs and commercial products, with activities conducted primarily in the United States.
See Also
- Five stocks we like better than Fortress Biotech
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
